TransMedics to Present at Upcoming March Investor Conferences

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) management will present at two investor conferences in March 2026: a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 1:50 p.m. EST, and a virtual presentation at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16, 2026 at 10:00 a.m. EST.

A live and archived webcast and the company's standard investor presentation will be available on the Investors section of the TransMedics website.

Argus Feb 18 session

+1.26% close to close Open Argus

Details

News Market Reaction – TMDX

In the Feb 18 session, TMDX gained 1.26%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights TransMedics’ upcoming visibility at two March investor conferences, wit...

Analysis

This announcement highlights TransMedics’ upcoming visibility at two March investor conferences, with sessions on March 2, 2026 and March 16, 2026. It follows recent regulatory milestones and expansion plans, which previously produced mixed share-price reactions. Investors may focus on any updated commentary shared in these webcasts versus prior disclosures, alongside the forthcoming earnings report and ongoing execution of growth and clinical trial initiatives.

Key Figures

TD Cowen conference number: 46th Annual Oppenheimer conference number: 36th Annual TD Cowen date: March 2, 2026 +4 more

TD Cowen conference number

46th Annual

TD Cowen 46th Annual Health Care Conference

Oppenheimer conference number

36th Annual

Oppenheimer 36th Annual Healthcare MedTech & Services Conference

TD Cowen date

March 2, 2026

TD Cowen 46th Annual Health Care Conference date

TD Cowen time

1:50 p.m. EST

Scheduled fireside chat time at TD Cowen conference

Oppenheimer date

March 16, 2026

Oppenheimer 36th Annual Healthcare MedTech & Services Conference date

Oppenheimer time

10:00 a.m. EST

Scheduled virtual presentation time at Oppenheimer conference

Number of conferences

2

Total investor conferences mentioned in the release

Historical Context

5 past events · Latest: Feb 10

5 events

1. Feb 10

   Earnings timing

   24h Move

   -4.3%

   Announcement of date and time for Q4 and full-year 2025 results.

2. Feb 09

   Regulatory approval

   24h Move

   +0.9%

   Full and unconditional FDA IDE approval for ENHANCE Heart trial.

3. Jan 12

   HQ expansion

   24h Move

   -1.8%

   New global headquarters lease and campus expansion in Somerville.

4. Dec 30

   Conference appearance

   24h Move

   -0.2%

   Planned presentation at the 44th Annual J.P. Morgan Healthcare Conference.

5. Dec 24

   Equity grants

   24h Move

   -2.2%

   Inducement stock options and RSUs granted to five new employees.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Feb. 17, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the TD Cowen 46^th Annual Health Care Conference in Boston on Monday, March 2, 2026, at 1:50 p.m. EST and virtually at the Oppenheimer 36^th Annual Healthcare MedTech & Services Conference on Monday, March 16, 2026, at 10:00 a.m. EST.

Event: TD Cowen 46^th Annual Health Care Conference
Date: Monday, March 2, 2026
Time: 1:50 p.m. EST

Event: Oppenheimer 36^th Annual Healthcare MedTech & Services Conference
Date: Monday, March 16, 2026
Time: 10:00 a.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-march-investor-conferences-302689917.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) present at the TD Cowen conference and how can I watch it?

TransMedics will present at TD Cowen on March 2, 2026 at 1:50 p.m. EST. According to the company, a live and archived webcast will be available on the Investors section of the TransMedics website, where the standard investor presentation is also posted.

What time is TransMedics (TMDX) scheduled to speak at the Oppenheimer Healthcare MedTech conference?

TransMedics is scheduled to present virtually at Oppenheimer on March 16, 2026 at 10:00 a.m. EST. According to the company, the session will be webcast live and archived on the Investors section of the TransMedics website.

Will TransMedics (TMDX) provide a replay of the March 2026 investor presentations?

Yes, TransMedics will provide an archived replay of both presentations. According to the company, the live and archived webcasts will be posted on the Investors section of the TransMedics website after each event.

What topics will TransMedics (TMDX) management cover in the March 2026 fireside chat?

The company announced management will participate in a fireside chat but did not list specific topics. According to the company, the session will follow the TD Cowen conference format and the investor presentation is available online.

Where can investors find TransMedics (TMDX) presentation materials for March 2026 events?

Investors can access presentation materials on the company's Investors website. According to the company, the standard investor presentation and live/archived webcasts for both March events are available at investors.transmedics.com.

Are TransMedics (TMDX) presentations in March 2026 in-person or virtual?

The TD Cowen fireside chat is in-person in Boston; the Oppenheimer presentation is virtual. According to the company, the TD Cowen session is March 2, 2026 at 1:50 p.m. EST and Oppenheimer is March 16, 2026 at 10:00 a.m. EST.